Where does Dr. Amr R Hassan practice?

Dr. Amr R Hassan practices at Burjeel Specialty Hospital, Sharjah

What is the specialty of Dr. Amr R Hassan?

Dr. Amr R Hassan specialty is Medical Oncologist

What is the experience of Dr. Amr R Hassan?

Dr. Amr R Hassan is Medical Oncologist with 12 years of experience.

What does a medical oncologist do?

A medical oncologist treats cancer using chemotherapy or other medications such as targeted therapy or immunotherapy.

What are the typical symptoms of cancer?

There may be Change in bowel or bladder habit, sore that does not heal, Unusual bleeding or discharge, Thickening or lump in the breast or elsewhere, Indigestion or difficulty in swallowing, Obvious change in a wart or mole and hoarseness in voice.

Which tests/ investigations are generally required by the medical oncologist ?

Tests like Biopsy, Bone Marrow Aspiration and Biopsy, Bone Scan, Breast MRI, Colonoscopy, Computed Tomography (CT) Scan, Digital Rectal Exam (DRE) etc are performed.

How long does the chemotherapy session lasts?

Chemotherapy session varies in length and frequency, it depends on the individual treatment plan prescribed by the doctor. Some last as long as three or four hours, while others may only take an half-hour.

What is the difference between a surgical oncologist and a medical oncologist?

A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy or immunotherapy wheras the surgical oncologist removes the tumor and nearby tissue during surgery.

Dr. Amr R Hassan, Medical Oncologist in Dubai, United Arab Emirates - Appointment

About Dr. Amr R Hassan

Dr. Amr R Hassan is a Consultant Medical Oncologist practicing for more than 12 years.
He holds extensive experience in managing Medical Oncology disorders and Hematologic diseases.
After completing his graduation in Biology and Medical Technology from Framingham State University, he pursued a Doctor of Medicine degree from Ross University School of Medicine followed by Residency in Internal Medicine at the University of Massachusetts Memorial Medical Centre, (UMass Medical School).
He achieved his fellowship in Hematology and Medical Oncology at the University of Massachusetts Memorial Medical Center (UMass Medical School).
He is professionally affiliated with various organizations including the American Society of Clinical Oncologists (ASCO), American College of Physicians (ACP), and American Society of Clinical Pathologists (ASCP).
He holds triple board certifications - The American Board of Internal Medicine (ABIM) in Medical Oncology, Hematology, and Internal Medicine.
He has papers and publications in peer-reviewed journals.

Hospital

Burjeel Specialty Hospital, Sharjah

Location

Dubai, United Arab Emirates

Special Interest

Breast Colon Head and neck A wide variety of other malignancies including Lymphoma

Book Appointment Contact Doctor

, Bachelor of Science in Biology and Medical Technology from Framingham State University.

DM, Doctor of Medicine degree from Ross University School of Medicine

, Residency in Internal Medicine at the University of Massachusetts Memorial Medical Centre, (UMass Medical School)

Fellowship, Hematology and Medical Oncology at the University of Massachusetts Memorial Medical Center (UMass Medical School)

Multi-center, randomized, double-blind phase III trial to evaluate efficiency and safety of B1695502 plus chemotherapy in patients with advanced non-squamous non-small cell lung cancer #2545.
A randomized phase 3 trial of the efficacy and safety of Glufosfamide compares with 5-FU in patients with metastatic pancreatic adenocarcinoma previously treated with Gemcitabine #2550
Development of risk- prediction models for chemotherapy-induced febrile neutropenia in patients with breast cancer, colorectal cancer, lung cancer, and non-Hodgkin lymphoma #2554
Prospective, non-interventional study of disease progression and treatment of patients with polycythemia vera in the United States academic and community clinical practices (REAVEL) #2555
A prospective observational cohort study of patients with castration-resistant prostate adenocarcinoma (CRPC) in the United States #2562
An open label two-stage study of orally administered BKM120 in patients with metastatic non-small cell lung cancer with active P13K pathway #2533
A randomized, double-blind, parallel-group, multi-center, phase 3 trial to compare the efficacy and tolerability of Fulvestrant (Faslodex) 500 mg with Anastrazole (Arimidex) 1 mg as hormonal treatment for postmenopausal women with hormone receptor positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy (FALCON) #2519